These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8979089)

  • 1. TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.
    Geltinger C; Hörtnagel K; Polack A
    Gene Expr; 1996; 6(2):113-27. PubMed ID: 8979089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.
    Wittekindt NE; Hörtnagel K; Geltinger C; Polack A
    Nucleic Acids Res; 2000 Feb; 28(3):800-8. PubMed ID: 10637333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.
    Polack A; Feederle R; Klobeck G; Hörtnagel K
    EMBO J; 1993 Oct; 12(10):3913-20. PubMed ID: 8404859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
    Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
    Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
    J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
    Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3' to the TATA box.
    Sjøttem E; Anderssen S; Johansen T
    J Virol; 1996 Jan; 70(1):188-98. PubMed ID: 8523525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
    Hu HM; Kanda K; Zhang L; Boxer LM
    Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter.
    Park NH; Guo W; Kim HR; Kang MK; Park NH
    Int J Oncol; 2001 Oct; 19(4):755-61. PubMed ID: 11562751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat.
    Boisclair YR; Brown AL; Casola S; Rechler MM
    J Biol Chem; 1993 Nov; 268(33):24892-901. PubMed ID: 7693708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity proteins Sp1 and Sp3 interact with the rat GTP cyclohydrolase I proximal promoter to regulate transcription.
    Chandran NS; Vunnava P; Wu Y; Kapatos G
    J Neurochem; 2008 Mar; 104(5):1233-48. PubMed ID: 18004997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma.
    Hu HM; Arcinas M; Boxer LM
    J Biol Chem; 2002 Mar; 277(12):9819-24. PubMed ID: 11777933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation.
    Krumm A; Hickey LB; Groudine M
    Genes Dev; 1995 Mar; 9(5):559-72. PubMed ID: 7698646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation functions of transcription factor Sp1 at U2 snRNA and TATA box promoters.
    Forsberg M; Ström AC; Lillhager P; Westin G
    Biol Chem Hoppe Seyler; 1995 Nov; 376(11):661-9. PubMed ID: 8962675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1c and Sp1 transactivate the P1 and P2 promoters of human c-myc synergistically.
    Wierstra I; Alves J
    Biochem Biophys Res Commun; 2007 Jan; 352(1):61-8. PubMed ID: 17141659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional characterization of the promoter region of the mouse LDH/C gene: enhancer-assisted, Sp1-mediated transcriptional activation.
    Yang J; Thomas K
    Nucleic Acids Res; 1997 Jun; 25(11):2213-20. PubMed ID: 9153323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site.
    Pelletier MR; Hatada EN; Scholz G; Scheidereit C
    Nucleic Acids Res; 1997 Oct; 25(20):3995-4003. PubMed ID: 9321649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter.
    Dusing MR; Wiginton DA
    Nucleic Acids Res; 1994 Feb; 22(4):669-77. PubMed ID: 8127716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.